Literature DB >> 27559191

Implementing the Use of Pharmacist Progress Notes in a Surgical ICU.

Tyler Sledge, Nick Lonardo, Heidi Simons, Wayne Shipley.   

Abstract

BACKGROUND: Critical care pharmacists are established and valuable members of the critical care team, however there is rarely written evidence of their daily involvement in the patient's electronic medical record (EMR). Documentation in the EMR has the advantage of ensuring a seamless pass-off and provides an opportunity to capture the pharmacist's cognitive and clinical impact in a way that traditional systems of tracking "interventions" fail to do. We investigated implementation of pharmacist progress notes in a surgical intensive care unit (ICU) and their utility in measuring pharmacist activity.
METHODS: Daily pharmacist progress notes written in a surgical ICU over a period of 2 months were reviewed. Each pharmacist action identified through progress note review was quantified and scored by an independent reviewer using a newly developed scoring system, the clinical impact score (CIS). This was developed as a way to quantify pharmacist actions and to classify those actions by clinical impact.
RESULTS: Four hundred sixty-two daily pharmacist progress notes were reviewed over a 2-month period. There were 1,055 actions identified that resulted in a therapy change. Four of these actions resulted in the potential avoidance of a sentinel event. Of patients with at least 5 progress notes (n = 44), the majority of pharmacist actions occurred on ICU day 1.
CONCLUSION: The results of this descriptive study demonstrate that the implementation of daily pharmacist progress notes is feasible in an advanced practice setting, and the pharmacist's contribution to patient care may be obtained through review of this documentation in the patient's medical record. The critical care pharmacist's daily involvement in patient care most commonly results in optimization of pharmacotherapy and avoidance of drug misadventure.

Entities:  

Keywords:  adverse drug event; clinical impact; collaboration; documentation; pharmacist

Year:  2016        PMID: 27559191      PMCID: PMC4981106          DOI: 10.1310/hpj5107-577

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  21 in total

1.  Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services.

Authors:  M I Rudis; K M Brandl
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

Review 2.  Medication errors in critical care: risk factors, prevention and disclosure.

Authors:  Eric Camiré; Eric Moyen; Henry Thomas Stelfox
Journal:  CMAJ       Date:  2009-04-28       Impact factor: 8.262

3.  What meaningful use means for pharmacy.

Authors:  Sammuel V Anderegg; Karl F Gumpper
Journal:  Am J Health Syst Pharm       Date:  2012-05-15       Impact factor: 2.637

4.  Interdisciplinary patient care in the intensive care unit: focus on the pharmacist.

Authors:  Brian L Erstad; Curtis E Haas; Terence O'Keeffe; Cheryl A Hokula; Kathleen Parrinello; Andreas A Theodorou
Journal:  Pharmacotherapy       Date:  2011-02       Impact factor: 4.705

5.  Do we need a pharmacist in the ICU?

Authors:  Clarence Chant; Norman F Dewhurst; Jan O Friedrich
Journal:  Intensive Care Med       Date:  2015-05-21       Impact factor: 17.440

6.  Documentation of medication changes in inpatient clinical notes: an audit to support quality improvement.

Authors:  Elsie Peusschers; Jaryth Twine; Amanda Wheeler; Vikas Moudgil; Sue Patterson
Journal:  Australas Psychiatry       Date:  2015-02-12       Impact factor: 1.369

7.  Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP© website observatory.

Authors:  P Bedouch; N Sylvoz; B Charpiat; M Juste; R Roubille; F-X Rose; J-L Bosson; O Conort; B Allenet
Journal:  J Clin Pharm Ther       Date:  2014-10-10       Impact factor: 2.512

8.  Clinical and economic impact of adverse drug reactions in hospitalized patients.

Authors:  D C Suh; B S Woodall; S K Shin; E R Hermes-De Santis
Journal:  Ann Pharmacother       Date:  2000-12       Impact factor: 3.154

9.  Cost effectiveness of a clinical pharmacist on a neurosurgical team.

Authors:  Kyle A Weant; John A Armitstead; Alim M Ladha; Deanna Sasaki-Adams; Eldad J Hadar; Matthew G Ewend
Journal:  Neurosurgery       Date:  2009-11       Impact factor: 4.654

10.  ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2012.

Authors:  Craig A Pedersen; Philip J Schneider; Douglas J Scheckelhoff
Journal:  Am J Health Syst Pharm       Date:  2013-05-01       Impact factor: 2.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.